NCT03541850 - Stereotactic Body Radiation Therapy in Treating Patients with Localized Prostate Cancer That Have Undergone Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2026

Conditions

PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) V7Stage II Prostate Adenocarcinoma AJCC V7Stage III Prostate Adenocarcinoma AJCC V7

Interventions

DRUG

Antiandrogen Therapy

Receive luteinizing hormone-releasing hormone agonist or gonadotropin-releasing hormone antagonist, and oral anti-androgen

OTHER

Quality-of-Life Assessment

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (2)

90033

USC Norris Comprehensive Cancer Center and Hospital, Los Angeles

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors

collaborator

Viewray Inc.

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER